Top

Published in:

25-07-2022 | Subacute Granulomatous Thyroiditis | Viewpoint

Thyroid function changes and COVID-19 severity: egg or chicken?

Authors: Wenjie Chen, Jianyong Lei, Zhihui Li

Published in: Endocrine | Issue 3/2022

Abstract

The novel coronavirus disease 2019 (COVID-19) produced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious infectious disease. In addition to typical flu-like symptoms, COVID-19 can also cause extrapulmonary spread and systemic inflammation, potentially causing multiorgan dysfunction, including thyroid dysfunction. Thyroid function changes in patients with COVID-19 have been widely reported, but the results are inconsistent. Based on available data, SARS-CoV-2 infection can lead to changes in thyroid function, and the degree of thyroid function changes was positively correlated with the severity of COVID-19, which involved multiple potential mechanisms. In contrast, current evidence was insufficient to prove that thyroid function changes could induce the progression of COVID-19 clinical deterioration.

M. Chen., W.B. Zhou, W.W. Xu. Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study. Thyroid. 2020. https://doi.org/10.1089/thy.2020.0363

R. Baldelli, E. Nicastri, N. Petrosillo, L. Marchioni, A. Gubbiotti, I. Sperduti et al. Thyroid dysfunction in COVID-19 patients. J. Endocrinol. Investig. 44(12), 2735–9 (2021). https://doi.org/10.1007/s40618-021-01599-0CrossRef

W. Gao, W. Guo, Y. Guo, M. Shi, G. Dong, G. Wang et al. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J. Endocrinol. Investig. 44(5), 1031–40 (2021). https://doi.org/10.1007/s40618-020-01460-wCrossRef

M. Guven, H. Gultekin, The prognostic impact of thyroid disorders on the clinical severity of COVID-19: Results of single-centre pandemic hospital. Int. J. Clin. Pract. 75(6), e14129 (2021). https://doi.org/10.1111/ijcp.14129CrossRefPubMed

D.T.W. Lui, C.H. Lee, W.S. Chow, A.C.H. Lee, A.R. Tam, C.H.Y. Fong et al. Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19. J. Clin. Endocrinol. Metab. 106(2), e926–e35 (2021). https://doi.org/10.1210/clinem/dgaa813CrossRefPubMed

D.T.W. Lui, C.H. Lee, W.S. Chow, A.C.H. Lee, A.R. Tam, C.H.Y. Fong et al. Role of non-thyroidal illness syndrome in predicting adverse outcomes in COVID-19 patients predominantly of mild-to-moderate severity. Clin. Endocrinol. 95(3), 469–77 (2021). https://doi.org/10.1111/cen.14476CrossRef

C. Sparano C., E. Zago, A. Morettini, C. Nozzoli, D. Yannas, V. Adornato, et al. Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease. J. Endocrinol. Investig. 2021. https://doi.org/10.1007/s40618-021-01714-1

T. Chen, D. Wu, H. Chen, W. Yan, D. Yang, G. Chen et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Bmj 368, m1091 (2020). https://doi.org/10.1136/bmj.m1091CrossRefPubMedPubMedCentral

F.E.L. Beltrao, D.C.A. Beltrao, G. Carvalhal, F.E.L. Beltrao, A.D.S. Brito, K. Capistrano et al. Thyroid Hormone Levels During Hospital Admission Inform Disease Severity and Mortality in COVID-19 Patients. Thyroid. 31(11), 1639–49 (2021). https://doi.org/10.1089/thy.2021.0225CrossRefPubMed

10.

M.A. Ballesteros Vizoso, A.F. Castilla, A. Barcelo, J.M. Raurich, P. Argente Del Castillo, D. Morell-Garcia, et al. Thyroid Disfunction in Critically Ill COVID-19 Patients. Relationship with In-Hospital Mortality. J. Clin. Med. 10, (2021). https://doi.org/10.3390/jcm10215057

11.

Y. Chen, X. Li, Y. Dai, J. Zhang, The Association Between COVID-19 and Thyroxine Levels: A Meta-Analysis. Front. Endocrinol. 12, 779692 (2021). https://doi.org/10.3389/fendo.2021.779692CrossRef

12.

G. Lisco, A. De Tullio, A. Stragapede, A.G. Solimando, F. Albanese, M. Capobianco, et al. COVID-19 and the Endocrine System: A Comprehensive Review on the Theme. J. Clin. Med. 10(13), (2021). https://doi.org/10.3390/jcm10132920

13.

P. Trimboli, C. Camponovo, S. Franscella, E. Bernasconi, N. Buetti, Subacute Thyroiditis during the COVID-19 Pandemic: Searching for a Clinical Association with SARS-CoV-2. Int. J. Endocrinol. 2021, 5588592 (2021). https://doi.org/10.1155/2021/5588592CrossRefPubMedPubMedCentral

14.

I. Pirola, E. Gandossi, M. Rotondi, F. Marini, A. Cristiano, L. Chiovato et al. Incidence of De Quervain’s thyroiditis during the COVID-19 pandemic in an area heavily affected by Sars-CoV-2 infection. Endocrine 74(2), 215–8 (2021). https://doi.org/10.1007/s12020-021-02841-8CrossRefPubMedPubMedCentral

15.

W. Chen, Y. Tian, Z. Li, J. Zhu, T. Wei, J. Lei. Potential Interaction Between SARS-CoV-2 and Thyroid: A Review. Endocrinology. 162(3), (2021). https://doi.org/10.1210/endocr/bqab004

16.

P. Trimboli, C. Cappelli, L. Croce, L. Scappaticcio, L. Chiovato, M. Rotondi, COVID-19-Associated Subacute Thyroiditis: Evidence-Based Data From a Systematic Review. Front. Endocrinol. 12, 707726 (2021). https://doi.org/10.3389/fendo.2021.707726CrossRef

17.

M. Hoffmann, H. Kleine-Weber, S. Schroeder, N. Kruger, T. Herrler, S. Erichsen et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181(2), 271–80 e8 (2020). https://doi.org/10.1016/j.cell.2020.02.052CrossRefPubMedPubMedCentral

18.

M.Y. Li, L. Li, Y. Zhang, X.S. Wang, Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty 9(1), 45 (2020). https://doi.org/10.1186/s40249-020-00662-xCrossRefPubMedPubMedCentral

19.

M. Rotondi, F. Coperchini, G. Ricci, M. Denegri, L. Croce, S.T. Ngnitejeu et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J. Endocrinol. Investig. 44(5), 1085–90 (2021). https://doi.org/10.1007/s40618-020-01436-wCrossRef

20.

B. Hanley, K.N. Naresh, C. Roufosse, A.G. Nicholson, J. Weir, G.S. Cooke et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe 1(6), e245–e53 (2020). https://doi.org/10.1016/S2666-5247(20)30115-4CrossRefPubMedPubMedCentral

21.

X.H. Yao, T.Y. Li, Z.C. He, Y.F. Ping, H.W. Liu, S.C. Yu et al. [A pathological report of three COVID-19 cases by minimal invasive autopsies]. Zhonghua bing li xue za zhi = Chinese journal of pathology 49(5), 411–7 (2020). https://doi.org/10.3760/cma.j.cn112151-20200312-00193

22.

L. Croce, D. Gangemi, G. Ancona, F. Liboa, G. Bendotti, L. Minelli et al. The cytokine storm and thyroid hormone changes in COVID-19. J. Endocrinol. Investig. 44(5), 891–904 (2021). https://doi.org/10.1007/s40618-021-01506-7CrossRef

23.

F. Coperchini, G. Ricci, L. Croce, M. Denegri, R. Ruggiero, L. Villani et al. Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study. Endocrine 74(3), 638–45 (2021). https://doi.org/10.1007/s12020-021-02807-wCrossRefPubMedPubMedCentral

24.

M.K. Leow, D.S. Kwek, A.W. Ng, K.C. Ong, G.J. Kaw, L.S. Lee, Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin. Endocrinol. 63(2), 197–202 (2005). https://doi.org/10.1111/j.1365-2265.2005.02325.xCrossRef

25.

J. Zheng, Z. Cui, N. Shi, S. Tian, T. Chen, X. Zhong et al. Suppression of the hypothalamic-pituitary-thyroid axis is associated with the severity of prognosis in hospitalized patients with COVID-19. BMC Endocr. Disord. 21(1), 228 (2021). https://doi.org/10.1186/s12902-021-00896-2CrossRefPubMedPubMedCentral

26.

M. van Gerwen, M. Alsen, C. Little, J. Barlow, L. Naymagon, D. Tremblay et al. Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study. Front. Endocrinol. 11, 565 (2020). https://doi.org/10.3389/fendo.2020.00565CrossRef

27.

T.H. Brix, L. Hegedus, J. Hallas, L.C. Lund, Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism. Lancet Diabetes Endocrinol. 9(4), 197–9 (2021). https://doi.org/10.1016/S2213-8587(21)00028-0CrossRefPubMedPubMedCentral

28.

P. Trimboli, C. Camponovo, L. Scappaticcio, G. Bellastella, A. Piccardo, M. Rotondi, Thyroid sequelae of COVID-19: a systematic review of reviews. Rev. Endocr. Metab. Disord. 22(2), 485–91 (2021). https://doi.org/10.1007/s11154-021-09653-1CrossRefPubMedPubMedCentral

29.

G. Van den Berghe, Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 24(10), 1456–65 (2014). https://doi.org/10.1089/thy.2014.0201CrossRefPubMedPubMedCentral

30.

G.A. Brent, J.M. Hershman, Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J. Clin. Endocrinol. Metab. 63(1), 1–8 (1986). https://doi.org/10.1210/jcem-63-1-1CrossRefPubMed

Title: Thyroid function changes and COVID-19 severity: egg or chicken?
Authors: Wenjie Chen
Jianyong Lei
Zhihui Li
Publication date: 25-07-2022
Publisher: Springer US
Keywords: Subacute Granulomatous Thyroiditis
SARS-CoV-2
COVID-19
Published in: Endocrine / Issue 3/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-022-03129-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Thyroid function changes and COVID-19 severity: egg or chicken?

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2022

Cortex or cancellous—which is early for the decrease of bone content for vertebral body in health?

The combination of BRAFV600E mutation and Chinese Thyroid Imaging Reporting and Data System is helpful in the management of AUS/FLUS thyroid nodules

Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes

Pregnancy after pituitary surgery does not influence the recurrence of Cushing’s disease

Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management

Predicting risk of obesity and meal planning to reduce the obese in adulthood using artificial intelligence

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page